Tecnovatica S.A. (WSE:TEC)

Market Cap	5.70M +29.9%
Revenue (ttm)	125.86K
Net Income	-87.83K
EPS	-0.01
Shares Out	10.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,296
Open	0.5300
Previous Close	0.5300
Day's Range	0.4770 - 0.5300
52-Week Range	0.2280 - 0.8560
Beta	0.43
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Tecnovatica

Tecnovatica S.A. engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets. Its areas of activity are NIPT prenatal diagnostics, genetic cancer diagnostics, artificial intelligence in diagnostics, telemedicine and mobile applications, medical marijuana and supportive therapies, and translational medicine and scientific cooperation. The company was formerly known as Vinci Gen S.A. and changed its name to Tecnovatica S.A. in ...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2010
• Employees: 1
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: TEC

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 5, 2026

Data Sources Report a data error